Liraglutide was not originally developed as a weight-loss treatment. Like semaglutide (Ozempic), it originally treated type 2 diabetes. The class of drugs liraglutide and semaglutide belong to are ...

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic is not ...

New data shows that more patients with type 2 diabetes achieved an average blood sugar level below 7% after using Novo Nordisk’s Victoza (liraglutide) for the first time, at any given time point ...

Liraglutide is on the market as Victoza for diabetes and Saxenda for obesity. It has been largely superseded, however, by Novo Nordisk's semaglutide-based therapies, Ozempic for diabetes and ...

Victoza is another injectable GLP-1 medication that is similar to Ozempic. It’s approved to lower blood sugar levels in adults with type 2 diabetes. However, unlike Ozempic, Victoza is injected ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Use of other weight loss medications, such as phentermine and liraglutide, declined. Among people with type 2 diabetes, 13% started GLP-1RA-based medications in January 2021. That rate rose to 35% ...

The approval of tirzepatide for type 2 diabetes and obesity management has ... phentermine, 3.0-mg liraglutide, 2.4-mg semaglutide, naltrexone–bupropion, orlistat, and phentermine–topiramate.